Artem O.
Surov
a,
Alexander P.
Voronin
a,
Ksenia V.
Drozd
a,
Andrei V.
Churakov
b,
Pascal
Roussel
c and
German L.
Perlovich
*ad
aInstitution of the Russian Academy of Sciences, G.A. Krestov Institute of Solution Chemistry RAS, 153045, Ivanovo, Russia. E-mail: glp@isc-ras.ru; Fax: (+7) 4932 336237; Tel: (+7) 4932 533784
bInstitute of General and Inorganic Chemistry RAS, 31 Leninsky Prosp, 119991 Moscow, Russia
cUCCS UMR 8181 University des Sciences et Technologies de Lille-1, Lille, France
dDepartment of Chemistry, Lomonosov Moscow State University, Moscow, Russia
First published on 29th December 2017
The crystallization of norfloxacin and ciprofloxacin – antibacterial fluoroquinolone compounds – with fumaric acid resulted in the isolation of six distinct solid forms of the drugs with different stoichiometries and hydration levels. Each salt can be selectively obtained by mechanochemical treatment in the presence of water/organic mixtures of a particular composition. The new phases were analysed using TG, DSC and PXRD, and their structural parameters were determined using single crystal X-ray diffraction. Despite having the same counterion, the ciprofloxacin and norfloxacin fumarates crystallise to form distinct crystal structures, which consequently determine the differences in the relative stability and the corresponding physicochemical properties of the solid forms. The influence of water activity (aw) on the solid form stability and transformation pathways of anhydrous and hydrated fumarates was elucidated. The solubility and phase stability of the salts were also investigated in pharmaceutically relevant buffer solutions with pH 6.8 and pH 1.2. The largest solubility improvement relative to the parent drug (≈33 times) in the pH 6.8 medium was observed in the case of ciprofloxacin hemifumarate sesquihydrate. In turn, the norfloxacin fumarates showed a moderate 3-fold enhancement in solubility.
The literature survey suggests that the fluoroquinolones tend to form salts with multiple stoichiometries and variable water content. For example, Velaga et al. reported a conventional salt and a salt-cocrystal of norfloxacin with saccharin.18 Paluch et al. were able to isolate six distinct solid forms of ciprofloxacin succinate, including four crystalline forms with various drug/acid stoichiometries and hydration levels, and two amorphous forms.9 The fact that several alternative solid forms coexist at the same temperature and pressure implies proximity in their Gibbs free energies. In the case of hydrates, water molecules make an important contribution to stabilizing the crystal lattice of a solid,26 filling the excess of the free volume (decreasing entropy) and connecting the constituents of the multi-component crystal via intermolecular interactions (increasing enthalpy). It is evident that any changes in the crystal structure of the solid form inevitably alter its physicochemical properties, including solubility and dissolution rate. Like polymorphic forms, salts with multiple drug/acid stoichiometries and/or water contents differ in their thermodynamic and physical stability and hence may undergo various solid state phase transformations (e.g. hydrate formation) depending on temperature, relative humidity, dissolution medium, etc. The effect of such transformations on the solubility performance of a salt is hard to predict. Therefore, it is important to take into account the tradeoff between the physicochemical properties of a particular solid form and its thermodynamic stability.
In this research, we report crystal structures, physicochemical properties, thermodynamic stability and solubility of the fumarate salts of ciprofloxacin and norfloxacin with different stoichiometry values and hydration levels. Although ciprofloxacin fumarate monohydrate (1:
1
:
1) and ciprofloxacin hemifumarate sesquihydrate (1
:
0.5
:
1.5) have been described earlier,10,12 norfloxacin salts with fumaric acid are reported for the first time. It has been found that each fluoroquinolone can form three distinct salt forms with fumaric acid, namely two forms with a 1
:
1 drug/acid stoichiometry and one form with a 1
:
0.5 drug/acid stoichiometry. A broad range of analytical techniques was applied to characterise the fumarate salts, including X-ray diffraction (powder and single crystal), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), water activity measurements (slurry method), dissolution and solubility investigation at the physiological pH values (1.2 and 6.8). It is known that experimental form screening is routinely conducted in the pharmaceutical industry to ensure that all the forms have been found and that the most appropriate solid form is developed.27 Therefore, the present work seeks to establish the influence of crystal structure and hydration level of the ciprofloxacin and norfloxacin fumarates on their stability and solubility with the aim of selecting the salt form with the optimal characteristics for further development.
X-ray powder diffraction (PXRD) data of the bulk materials were recorded under ambient conditions in a Bragg–Brentano geometry with a Bruker D8 Advance diffractometer with CuKα1 radiation (λ = 1.5406 Å).
aw = 0.0056 + 1.398·xw − 0.647·xw2 + 0.153·xw3 + 0.0845·xw4 | (1) |
In a typical experiment, 30 mg of [Cip + Fum] (1:
1) or [NFX + Fum + H2O] (1
:
1
:
1) was suspended in 1.6 ml of a water–methanol mixture in a sealed vial and left to shake at 25 °C for at least 4 days. Where stated, the initial suspension was seeded with an alternative phase to initiate phase transition. After equilibration, the suspension was centrifuged, the clear solution was filtered through a 0.22 μm PTFE filter and the concentration of fluoroquinolone was measured by absorbance spectroscopy after necessary dilution using a Cary 50 UV-vis spectrophotometer (Varian) at the reference wavelength. In each experiment, the precipitate was collected, dried carefully at room temperature and identified by PXRD.
Compound reference | [NFX + Fum + H2O] (1![]() ![]() ![]() ![]() |
[NFX + Fum + H2O] (1![]() ![]() ![]() ![]() |
[NFX + Fum + H2O] (1![]() ![]() ![]() ![]() |
[CIP + Fum] (1![]() ![]() |
---|---|---|---|---|
Chemical formula | C16H19FN3O3·C4H3O4·1(H2O) | C16H19FN3O3·C4H3O4·2(H2O) | C16H19FN3O3·0.5(C4H2O4)·1(H2O) | C17H19FN3O3·C4H3O4·0.155(H2O) |
Fw | 453.42 | 471.44 | 790.77 | 450.21 |
Crystal system | Monoclinic | Monoclinic | Triclinic | Monoclinic |
Space group | P21/c | P21/n |
P![]() |
P21/c |
a/Å | 16.6277(4) | 8.1127(8) | 6.7869(4) | 8.0133(9) |
b/Å | 7.3695(2) | 9.6281(9) | 9.3544(6) | 37.244(4) |
c/Å | 17.1695(5) | 27.380(3) | 15.7300(9) | 6.9698(8) |
α/° | 90 | 90 | 93.6351(9) | 90 |
β/° | 100.1910(10) | 93.525(2) | 92.6297(9) | 92.806(2) |
γ/° | 90 | 90 | 110.9168(9) | 90 |
Unit cell volume/Å3 | 2070.72(10) | 2134.6(4) | 928.45(10) | 2077.6(4) |
No. of formula units per unit cell, Z | 4 | 4 | 1 | 4 |
Temperature/K | 100 | 150 | 150 | 150 |
Absorption coefficient, μ/mm−1 | 0.119 | 0.122 | 0.113 | 0.115 |
No. of reflections measured | 41493 | 17344 | 10525 | 22847 |
No. of independent reflections | 4578 | 3782 | 4924 | 5508 |
R int | 0.032 | 0.0546 | 0.0141 | 0.0305 |
Final R1 values (I > 2σ(I)) | 0.0367 | 0.0392 | 0.0359 | 0.0427 |
Final wR(F2) values (I > 2σ(I)) | 0.0943 | 0.0810 | 0.0985 | 0.1072 |
Final R1 values (all data) | 0.0442 | 0.0613 | 0.0418 | 0.0545 |
Final wR(F2) values (all data) | 0.0989 | 0.0898 | 0.1034 | 0.1150 |
Goodness of fit on F2 | 1.028 | 1.021 | 1.040 | 1.025 |
Largest diff. peak & hole, e Å−3 | 0.340/−0.210 | 0.177/−0.194 | 0.381/−0.235 | 0.432/−0.233 |
![]() | ||
Fig. 2 Illustration of hydrogen bond patterns in the crystals of (a) [NFX + Fum + H2O] (1![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
[NFX + Fum + H2O] (1:
1
:
1) consists of conventional layers of columnar π-stacks of the drug separated by domains containing fumarate ions and water molecules (Fig. 4b). In the [NFX + Fum + H2O] (1
:
1
:
2) structure, the layers are less prominent (Fig. 4a). The H-bonded chains of fumarate ions are located inside the voids formed by NFX, whereas H2O molecules reside in the hydrophilic surroundings of carboxylic and piperazinyl. In the [NFX + Fum + H2O] (1
:
0.5
:
1) crystal, the fully deprotonated anion of fumaric acid accepts charge-assisted N +–H⋯O− hydrogen bonds from two NFX molecules to form a centrosymmetrical trimeric unit.
![]() | ||
Fig. 4 Packing arrangement of (a) [NFX + Fum + H2O] (1![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
The water molecules are located between the adjacent fumarate ions, uniting the counterions via hydrogen bonding into a single layer which is extended along the a-axis (Fig. 5a). Interestingly, H2O molecules act only as donors of hydrogen bonds, while the water oxygen does not seem to get involved in strong interactions. As seen in Fig. 4b and 5b, the crystals of [NFX + Fum + H2O] (1:
1
:
1) and [NFX + Fum + H2O] (1
:
0.5
:
1) have some common packing features. In both forms, the NFX ions are arranged in structurally almost identical π-stacks, separated by layers of counterions and water molecules. This leads to the suggestion that the spatial arrangement of NFX in these crystals is favorable in terms of packing energy, and it can play the role of a supramolecular framework, allowing counterions and water molecules to be placed in different ways within the framework. This assumption is supported by the fact that the [NFX + Fum + H2O] (1
:
0.5
:
1) salt is found to have an isostructural counterpart, namely norfloxacin succinate monohydrate ([NFX + succinic + H2O] (1
:
0.5
:
1) – VETWAT, Fig. S9†). Taking into account that (i) isomorphism is quite a rare event among fluoroquinolone multi-component crystals and (ii) there is no evidence that there are other forms of [NFX + succinic + H2O] (1
:
0.5
:
1),7 it can be concluded that the packing arrangement of NFX ions in the fumarate and succinate salts is associated with the low Gibbs free energy value and is, therefore, more stable than all possible alternatives.
![]() | ||
Fig. 5 Illustration of (a) hydrogen bonds and (b) molecular packing projection in the [NFX + Fum + H2O] (1![]() ![]() ![]() ![]() |
According to single-crystal X-ray data, the [CIP + Fum] (1:
1) salt sample obtained by solution crystallization contained 0.16 water molecules per 1 molecule of the salt. Nevertheless, the water molecules do not play a significant role in the crystal structure, as seen in Fig. S10,† forming only two weak (DO⋯O > 2.9 Å, DH⋯O > 2.2 Å) hydrogen bonds with neighbouring fumarate ions, and thus can be considered as inclusions of crystallization water. The calculated PXRD pattern from the crystal structure was found to be in an excellent agreement with the experimental one for the anhydrous salt, indicating that single crystal X-ray data is consistent with the bulk material generated by grinding (Fig. S7†). As in the systems described above, in the [CIP + Fum] (1
:
1) crystal, the fumarate ions are connected by short (DO⋯O > 2.47 Å, DH⋯O > 1.35 Å) hydrogen bonds to form infinite chains with the C(7) graph set notation. Each CIP cation is involved in hydrogen bonding with two neighbouring chains, which are extended at an angle of ≈47° to each other (Fig. 6a). The packing arrangement of the salt consists of alternating layers containing the conventional π-stacks of CIP and the perpendicularly oriented hydrogen bonded chains of the acid (Fig. 6b).
![]() | ||
Fig. 6 Illustration of (a) hydrogen bonds and (b) molecular packing projection in the [CIP + Fum] (1![]() ![]() |
The asymmetric unit of the [CIP + Fum + H2O] (1:
0.5
:
1.5) salt contains two cations of the drug, one anion of the acid and three water molecules. Both of the carboxylic groups of fumaric acid are deprotonated and accept multiple hydrogen bonds. There are nine H-bonds from the surrounding CIP cations and water molecules per fumaric dianion. Two of the three water molecules in the structure act as linkers between the separate fumarate ions, while the third one connects the carboxylic groups of ciprofloxacin to the counterion (Fig. S11a†). The components of the salt are packed in a conventional layer-like manner, which is characterised by alternating hydrophobic and hydrophilic regions containing the fluoroquinolone moieties and hydrated dianions of fumaric acid, respectively (Fig. S11b†).
![]() | ||
Fig. 7 DSC curves for different forms of ciprofloxacin and norfloxacin fumarates recorded at a 10°C min−1 heating rate. |
T dehyd, °C | ΔHdehyd, J g−1 | ΔmS, % | T fus, °C | ΔHfus, J g−1 | ΔHS, kJ mol−1 | |
---|---|---|---|---|---|---|
a The data is taken from ref. 8. | ||||||
NFX | 220.0 | |||||
[NFX + Fum + H2O] (1![]() ![]() ![]() ![]() |
83.1 ± 1.5 | 129.0 ± 4.0 | 3.90 | 229.0 ± 2.0 | 230.0 ± 4.0 | 58.7 |
[NFX + Fum + H2O] (1![]() ![]() ![]() ![]() |
75.9 ± 1.7 | 212.4 ± 3.5 | 7.32 | 201.8 ± 1.5 | 219.0 ± 3.5 | 48.2 |
[NFX + Fum + H2O] (1![]() ![]() ![]() ![]() |
89.3 ± 1.5 | 131.3 ± 2.0 | 4.65 | 227.1 ± 2.0 | 148.3 ± 3.0 | 51.9 |
CIP | 271.0 | |||||
[CIP + Fum + H
2
O]
(1![]() ![]() ![]() ![]() |
141.0 ± 0.8 | 156.5 ± 4.0 | 3.90 | 203.8 ± 0.9 | 216.7 ± 5.0 | 72.8 |
[CIP + Fum + H
2
O] (1![]() ![]() ![]() ![]() |
102.5 ± 2.0 | 137.8 ± 4.5 | 6.20 | 226.7 ± 3.0 | 117.5 ± 4.0 | 38.3 |
[CIP + Fum] (1![]() ![]() |
n/a | n/a | n/a | 227.8 ± 0.8 | 241.2 ± 3.0 | n/a |
The large difference between the thermal stability of the hydrates indicates that the interaction energies between the solvent molecules and the host structure of the salts are different. The binding strength of the solvent in the hydrated salts can be estimated by calculating the enthalpy of vaporization (ΔHS) of the salt-bound solvent using the following relationship:34
ΔHS = (ΔHTdesolv × 100/ΔmS)·MS | (2) |
The resulting ΔHS values for the solvates are shown in Table 2. It is evident that in [CIP + Fum + H2O] (1:
1
:
1), the water molecules are more tightly bound to the host structure than those in [NFX + Fum + H2O] (1
:
1
:
1), resulting in an unusually high dehydration temperature of the former salt. Despite the relatively small Tdehyd values of the norfloxacin fumarate hydrates, the ΔHS parameter indicates stronger interactions of H2O molecules with the salt crystal environment than in the pure liquid (vaporization enthalpy of water, ≈40.7 kJ mol−1). In the [CIP + Fum + H2O] (1
:
0.5
:
1.5) salt, however, the ΔHS value is comparable with the enthalpy of pure water vaporization.
The DSC data also show that the products of the salt dehydration have different melting temperatures (Table 2). For example, the dehydrated forms of [NFX + Fum + H2O] (1:
1
:
1) and [NFX + Fum + H2O] (1
:
1
:
2) can be considered as two polymorphs of anhydrous norfloxacin fumarate. Interestingly, the temperature and enthalpy of the melting process of the monohydrate form which is less stable at room temperature are higher than those of the [NFX + Fum + H2O] (1
:
1
:
2) salt. According to the ΔHfus values, when dehydrated, most of the salts remained highly crystalline materials. For [CIP + Fum + H2O] (1
:
0.5
:
1.5) and [NFX + Fum + H2O] (1
:
0.5
:
1), however, loss of solvent molecules reduced the crystallinity of the salts and decreased the melting heat effect. However, the dehydration products were found to be hydroscopic when exposed to air for several minutes, regaining the missing water content, making them unable to be characterised by X-ray diffraction methods.
Asolid + nH2O ↔ A·nH2Osolid | (3) |
![]() | (4) |
![]() | (5) |
In order to establish the thermodynamic stability ranges of the different crystalline forms of ciprofloxacin and norfloxacin fumarates, solubility experiments in water/methanol mixtures of various compositions were performed. The details of the experimental procedure are provided in the Materials and methods section.
The phase solubility diagram for the ciprofloxacin fumarate salts as a function of water activity (aw) in water/methanol mixtures is shown in Fig. 8. Anhydrous [CIP + Fum] (1:
1) was used as the starting phase in all the experiments. Analysis of the residual phases revealed that [CIP + Fum] (1
:
1) remained stable at a water activity aw of < 0.42. At aw > 0.44, the [CIP + Fum + H2O] (1
:
1
:
1) salt was the only solid phase at equilibrium, suggesting that the equilibrium (critical) water activity of the transition from anhydrous form to monohydrate was about 0.43. According to eqn (5), the Gibbs energy of the hydration process was calculated to be −2.0 kJ mol−1.
As Fig. 8 shows, the value of the equilibrium water activity corresponds to the maximum of the salt solubility in the mixture. It is evident that the presence and position of this maximum is a consequence of various factors, including the solid state of the equilibrium phase and solvation of ciprofloxacin and the counterion in the water/methanol solution. This issue, however, is beyond the scope of the current work. In order to verify the stability range of [CIP + Fum] (1:
1), the slurries of the anhydrous salt were seeded with [CIP + Fum + H2O] (1
:
1
:
1) at several aw < 0.43 points and left to equilibrate for 3 days. However, no evidence of a phase transition was observed, confirming the thermodynamic stability of the [CIP + Fum] (1
:
1) form in the tested aw region.
In the case of NFX salts, the initial phase for the solubility experiments was [NFX + Fum + H2O] (1:
1
:
1). The phase transitions between the hydrates of the norfloxacin fumarates are not straightforward compared to the anhydrate/hydrate of ciprofloxacin fumarate. As Fig. 9 indicates, the [NFX + Fum + H2O] (1
:
1
:
1) form was stable until the water activity reached a value of aw = 0.33. However, a further increase in aw resulted in the transformation of fumarate monohydrate (1
:
1
:
1) into hemifumarate monohydrate (1
:
0.5
:
1). However, the [NFX + Fum + H2O] (1
:
1
:
1) → [NFX + Fum + H2O] (1
:
1
:
2) phase transition would be more expected in this case. PXRD analysis of the residual materials revealed that [NFX + Fum + H2O] (1
:
0.5
:
1) was the only solid phase at the equilibrium up to aw = 0.74. At aw > 0.76, the [NFX + Fum + H2O] (1
:
1
:
2) hydrate was found to be the most thermodynamically stable form.
The results suggest alternative transformation pathways of the [NFX + Fum + H2O] (1:
1
:
1) form as a function of solvent composition. It seems that spontaneous transition of the norfloxacin fumarate monohydrate to dihydrate occurs only in a water-rich region of the methanol/water mixture (aw > 0.76). At water activities less than 0.76, the [NFX + Fum + H2O] (1
:
1
:
1) → [NFX + Fum + H2O] (1
:
0.5
:
1) transition becomes thermodynamically favored.
A similar phenomenon has been recently described by Tieger et al.39 for different polymorphic forms of sitagliptin L-tartrate, the stability order of which altered depending on the aw value of the water/organic mixture.
To make sure that the [NFX + Fum + H2O] (1:
1
:
1) → [NFX + Fum + H2O] (1
:
0.5
:
1) phase transition depends solely on water activity and is not affected by the organic solvent, [NFX + Fum + H2O] (1
:
1
:
1) was slurried in two water/alcohol mixtures (EtOH/H2O,40 IPA/H2O31) with a constant aw value equaling 0.5. The subsequent PXRD analysis showed that in both mixtures the transformation of fumarate monohydrate (1
:
1
:
1) to hemifumarate monohydrate (1
:
0.5
:
1) took place (Fig. S13†), confirming the fact that water activity is the major factor determining the nucleation and growth of the [NFX + Fum + H2O] (1
:
0.5
:
1) phase.
As the next step, we analysed the influence of [NFX + Fum + H2O] (1:
0.5
:
1) additives (seeds) on [NFX + Fum + H2O] (1
:
1
:
1) hydrate stability. The slurries of the [NFX + Fum + H2O] (1
:
1
:
1) salt were seeded with a small amount of [NFX + Fum + H2O] (1
:
0.5
:
1) at several aw < 0.43 (0.10, 0.14, 0.21, 0.25, 0.30) points and left to equilibrate for 3 days. It was observed that addition of the hemifumarate monohydrate (1
:
0.5
:
1) promoted the [NFX + Fum + H2O] (1
:
1
:
1) → [NFX + Fum + H2O] (1
:0.5
:
1) phase transition at all the studied compositions. This observation indicates that [NFX + Fum + H2O] (1
:
1
:
1) is a less thermodynamically stable form than [NFX + Fum + H2O] (1
:
0.5
:
1). However, similar seeding experiments at aw > 0.76 had no influence on the transformation pathway of the fumarate monohydrate (1
:
1
:
1), i.e. [NFX + Fum + H2O] (1
:
1
:
1) → [NFX + Fum + H2O] (1
:
1
:
2).
Based on the experimental results, it is possible to rationalise the thermodynamic stability relationship between different hydrates of the norfloxacin fumarates. The [NFX + Fum + H2O] (1:
1
:
1) salt was found to be metastable at all aw values. The apparent long-term stability of this form at aw < 0.33 seems likely to be due to the low solubility of the salt (Fig. 11) which results in a high activation barrier of nucleation of the stable phase, i.e. [NFX + Fum + H2O] (1
:
0.5
:
1). The seeding of [NFX + Fum + H2O] (1
:
1
:
1) solutions with the stable form diminishes the nucleation barrier and makes the phase transformation possible even at aw = 0.1. With an increase in water activity, the solute–solvent interaction accelerates the nucleation and growth rate of hemifumarate monohydrate (1
:
0.5
:
1), leading to a spontaneous [NFX + Fum + H2O] (1
:
1
:
1) → [NFX + Fum + H2O] (1
:
0.5
:
1) transition at aw > 0.33. In a water-rich region of the methanol/water mixture (aw > 0.76), the formation of the [NFX + Fum + H2O] (1
:
1
:
2) form is thermodynamically preferred, resulting in fumarate monohydrate transition to a dihydrate. Therefore, by carefully choosing aw (solution composition), it is possible to crystallise three hydrates of the norfloxacin fumarates; otherwise, concomitant crystallisation of solid forms may be observed. Moreover, water activity is the major factor that determines the outcome of the liquid-assisted grinding reaction (see 3.1), leading to the selective formation of [CIP + Fum] (1
:
1) and [NFX + Fum + H2O] (1
:
1
:
1) in the presence of solvent mixtures with low aw, and yielding [CIP + Fum + H2O] (1
:
1
:
1) and [NFX + Fum + H2O] (1
:
1
:
2) at high aw values.
![]() | ||
Fig. 10 Dissolution profiles and transformation pathways for (a) [CIP + Fum] (1![]() ![]() ![]() ![]() ![]() ![]() |
Salt/API | Solubility (S), mol l−1 | Solid phase recovered after 48 h | ||
---|---|---|---|---|
pH 6.8 | pH 1.2 | pH 6.8 | pH 1.2 | |
CIP | (2.44 ± 0.09) × 10−4 | (6.50 ± 0.10) × 10−2 | CIP hydrate | CIP hydrate |
[CIP + Fum + H2O] (1![]() ![]() ![]() ![]() |
(5.50 ± 0.10) × 10−3 | (2.65 ± 0.08) × 10−2 | [CIP + Fum + H2O] (1![]() ![]() ![]() ![]() |
[CIP + Fum + H2O] (1![]() ![]() ![]() ![]() |
[CIP + Fum + H2O] (1![]() ![]() ![]() ![]() |
(8.00 ± 0.20) × 10−3 | (7.70 ± 0.20) × 10−2 | [CIP + Fum + H2O] (1![]() ![]() ![]() ![]() |
[CIP + Fum + H2O] (1![]() ![]() ![]() ![]() |
NFX | (1.60 ± 0.05) × 10−3 | (6.80 ± 0.10) × 10−2 | NFX hydrate | NFX hydrate |
[NFX + Fum + H2O] (1![]() ![]() ![]() ![]() |
(4.80 ± 0.10) × 10−3 | (5.30 ± 0.10) × 10−2 | Mixture of [NFX + Fum + H2O] (1![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
[NFX + Fum + H2O] (1![]() ![]() ![]() ![]() |
[NFX + Fum + H2O] (1![]() ![]() ![]() ![]() |
(5.14 ± 0.09) × 10−3 | (7.90 ± 0.30) × 10−2 | [NFX + Fum + H2O] (1![]() ![]() ![]() ![]() |
[NFX + Fum + H2O] (1![]() ![]() ![]() ![]() |
[NFX + succinic + H2O] (1![]() ![]() ![]() ![]() |
(5.24 ± 0.10) × 10−3 | [NFX + succinic + H2O] (1![]() ![]() ![]() ![]() |
We suppose that the difference in stability of salts with (1:
1) and (1
:
0.5) stoichiometries has its origin in the ratio of solubilities of individual components. As is known from the literature, the solubility of pure NFX in mixed water–methanol media at 25 °C is within 0.02–0.04 mg L−1.41 The solubility of fumaric acid rapidly increases with the amount of methanol in the system from 1.19 × 10−3 mole fr. at x(MeOH) = 0.073 to 2.47 × 10−2 mole fr. at x(MeOH) = 0.800.42 By comparing these data using the known equations for the density of water–methanol mixtures,43 one can observe that the ratio of mole fraction solubilities xFum/xNFX changes from ca. 3600 at aw = 0.26 to only ca. 380 at aw = 0.92, i.e. in about ten times. Hence, dissolving [NFX + Fum + H2O] (1
:
1
:
1) in methanol-rich solutions where the solubility of norfloxacin is three orders lower than that of fumaric acid results in NFX supersaturation and phase transition into the form with a higher API/counterion ratio, i.e. [NFX + Fum + H2O] (1
:
0.5
:
1). In water-rich regions of the phase diagram, the xFum/xNFX ratio is much lower, and [NFX + Fum + H2O] (1
:
0.5
:
1) appears to be less stable than dihydrated [NFX + Fum + H2O] (1
:
1
:
2). This phenomenon is commonly observed in cocrystals of different API/coformer ratios.44,45
A similar tendency is observed when pure NFX and fumaric acid are dissolved in aqueous buffer solutions with different pH values,46,47 with xFum/xNFX values higher in acidic media and lower at neutral pH, leading to greater stability of [NFX + Fum + H2O] (1:
0.5
:
1) in the pH 6.8 solution.
The dissolution profiles for the unstable salts demonstrate the so-called “spring and parachute” behavior48 (Fig. 10). It is evident that the transformation rates of the metastable forms of the CIP and NFX fumarates are considerably different. For [CIP + Fum] (1:
1) at pH 6.8, it took about 4 hours to complete the transformation into the hydrated form. At pH 1.2, the process lasted more than 7 hours (Fig. 10a). In contrast, formation of [NFX + Fum + H2O] (1
:
1
:
2) and [NFX + Fum + H2O] (1
:
0.5
:
1) from [NFX + Fum + H2O] (1
:
1
:
1) at pH 1.2 and pH 6.8, respectively, occurred within 1 hour (Fig. 10b).
The largest value of the relative solubility (≈33 times) in pH 6.8 medium is observed for the [CIP + Fum + H2O] (1:
0.5
:
1.5) salt (Fig. 11), which is in agreement with the results obtained by Zhang et al.12 This result may be a consequence of the following factors: (i) better hydration of the fumarate dianion compared to the monoanion; (ii) loosely bound water molecules in the [CIP + Fum + H2O] (1
:
0.5
:
1.5) crystal, which are likely to diffuse easily between the crystal lattice and solution.
The obtained data suggest that the crystal structure is the key factor that determines solubility of the salts at pH 6.8. The result is quite expected in this case as all the studied salts have different packing arrangements, and yet contain the same counterion. The latter allowed us to assume that the hydration contribution to salt solubility is approximately constant (at least for the salts with the same API/fumaric molar ratio). Therefore, it would be interesting to analyse the reverse situation in order to estimate the influence of counterion replacement on salt solubility provided that the packing arrangement of the salt is preserved. Such an analysis can be performed using two isostructural NFX salts, i.e. [NFX + Fum + H2O] (1:
0.5
:
1) and [NFX + succinic + H2O] (1
:
0.5
:
1) (Fig. S9†).
The solubility of succinic acid in water is about one order of magnitude higher than that of fumaric acid,51 partially due to the difference in hydration. If we assume that the counterion hydration has a significant effect on salt solubility, then [NFX + succinic + H2O] (1:
0.5
:
1) should be more soluble than [NFX + Fum + H2O] (1
:
0.5
:
1). The experimental data indicate that the solubilities of the fumarate and succinate salts at pH 6.8 are closely comparable (Table 3) suggesting that counterion replacement has less impact on the salt solubility compared to the alteration in the crystal structure.
In contrast to the pH 6.8 medium, the solubility values of CIP and NFX in an acidic pH 1.2 buffer solution are similar, indicating a significant increase in hydration energy of the protonated species. It is evident that the solubility of the salts is mainly determined by solvent–solute interactions in a solution (hydration term), while the crystal structure plays a much less important role under the current conditions. A small solubility improvement compared to the parent drugs is observed only in the salts which contain a dianion of fumaric acid (2:
1 molar ratio). The fumarates, however, have relative solubility values below one (Table 3, Fig. 11).
It should also be noted that the dissolution rate of [NFX + Fum + H2O] (1:
1
:
1) exceeds that of [CIP + Fum] (1
:
1) by a factor of ca. 1.5. From kinetic considerations, the rate of solution phase transformation in the crystallization medium depends largely on the absolute and relative solubilities of the forms at that temperature. The higher the solubilities and the greater the difference in the solubilities of the two forms, the greater is the rate of transformation.52 It can be assumed, therefore, that the observed difference in the transformation rates of these salts during the powder dissolution (see 3.4.1, Fig. 10) is due to the differences in solubility and dissolution rate of the metastable forms.
Footnote |
† Electronic supplementary information (ESI) available: Results of mechanochemical search for crystal forms (Tables S1 and S2), TG and DSC analysis (Fig. S1, S2, S4, S5 and S12) experimental and calculated PXRD patterns (Fig. S3 and S6–S8), illustration of molecular packing arrangements of the [NFX + Succinic + H2O] (1![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
This journal is © The Royal Society of Chemistry 2018 |